Behavioral effects of nicotinic antagonist mecamylamine in a rat model of depression: Prefrontal cortex level of BDNF protein and monoaminergic neurotransmitters

Psychopharmacology

Volumn 232, Issue 6, 2015, Pages 1095-1105

  Aboul Fotouh, Sawsan ^a,b  

^a African Union Organization St Abbassia   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Anhedonia; Chronic restraint stress; Forced swimming test; Mecamylamine; Neurogenesis; Prefrontal cortex

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; MECAMYLAMINE; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN; NICOTINIC RECEPTOR BLOCKING AGENT;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ANXIETY; ARTICLE; BODY WEIGHT; BRAIN LEVEL; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; FORCED SWIM TEST; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION STRESS; MALE; NEUROCHEMISTRY; NONHUMAN; ORGAN WEIGHT; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SUCROSE PREFERENCE TEST; TRANQUILIZING ACTIVITY; ANIMAL; DISEASE MODEL; DRUG EFFECTS; EXERCISE; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MENTAL STRESS; METABOLISM; SWIMMING; WISTAR RAT;

ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; BRAIN-DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MECAMYLAMINE; NICOTINIC ANTAGONISTS; NOREPINEPHRINE; PITUITARY-ADRENAL SYSTEM; PREFRONTAL CORTEX; RATS; RATS, WISTAR; RESTRAINT, PHYSICAL; SEROTONIN; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 84923630828     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3745-5     Document Type: Article

References (55)

1. Aboul-Fotouh S (2013a) Chronic treatment with coenzyme Q10 reverses restraint stress-induced anhedonia and enhances brain mitochondrial respiratory chain and creatine kinase activities in rats. Behav Pharmacol 24(7):552-560
2. Aboul-Fotouh S (2013b) Coenzyme Q10 displays antidepressant-like activity with reduction of hippocampal oxidative/nitrosative DNA damage in chronically stressed rats. Pharmacol Biochem Behav 104:105-112
3. Anacker C, Zunszain PA, Carvalho LA, Pariante CM (2011) The glucocorticoid receptor: pivot of depression and of antidepressant treatment? Psychoneuroendocrinology 36:415-425
4. Andreasen JT, Redrobe JP (2009) Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests. Behav Brain Res 97(1):150-156
5. Andreasen JT, Olsen GM, Wiborg O, Redrobe JP (2009) Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests. J Psychopharmacol 23(7):797-804
6. Andreasen JT, Henningsen K, Bate S, Christiansen S, Wiborg O (2011) Nicotine reverses anhedonic-like response and cognitive impairment in the rat chronic mild stress model of depression: comparison with sertraline. J Psychopharmacol 25(8):1134-1141
7. Bacher I, Rabin R, Woznica A, Sacco KA, George TP (2010) Nicotinic receptor mechanisms in neuropsychiatric disorders: therapeutic implications. Prim Psychiatry 17(1):35-41
8. Braga RI, Ghiţə MA, Lupuoru M, Lupuşoru GE, Zəgrean L (2013) Nicotine displays antidepressant activity during the rat forced swimming test. Acta Med Transilvanica 2(3):272-274
9. Bravo JA, Díaz-Veliz G, Mora S, Ulloa JL, Berthoud VM, Morales P (2009) Desipramine prevents stress-induced changes in depressive-like behavior and hippocampal markers of neuroprotection. Behav Pharmacol 20:273-285
10. Buccafusco JJ, Beach JW, Terry AV (2009) Desensitization of nicotinic acetylcholine receptors as a strategy for drug development. J Pharmacol Exp Ther 328(2):364-370
11. Bugajski J, Gadek-Michalska A, Bugajski AJ (2002) Involvement of prostaglandins in the nicotine-induced pituitary-adrenocortical response during social stress. J Physiol Pharmacol 53:847-857
12. Caldarone BJ, Harrist A, Cleary MA, Beech RD, King SL, Picciotto MR (2004) High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation. Biol Psychiatry 56(9):657-664
13. Chen J-X, Li W, Zhao X, Yang J-X (2008) Effects of the Chinese traditional prescription Xiaoyaosan decoction on chronic immobilization stress-induced changes in behavior and brain BDNF, TrkB, and NT-3 in rats. Cell Mol Neurobiol 28:745-755
14. Chiba S, Numakawa T, Ninomiya M, Richards MC, Wakabayashi C, Kunugi H (2012) Chronic restraint stress causes anxiety- and depression-like behaviors, downregulates glucocorticoid receptor expression, and attenuates glutamate release induced by brain-derived neurotrophic factor in the prefrontal cortex. Prog Neuropsychopharmacol Biol Psychiatry 39(1):112-119
15. Corvin A, O'mahony E, O'regan M, Comerford C, O'connell R, Craddock N, Gill M (2001) Cigarette smoking and psychotic symptoms in bipolar affective disorder. Br J Pharmacol 179:35-38
16. Delgado PL, Miller HL, Salomon RM, Licinio J, Heninger GR, Gelenberg AJ, Charney DS (1993) Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressants. Psychopharmacol Bull 29(3):389-396
17. Delgado PL, Price LH, Miller HL, Salomon RM, Aghajanian GK, Heninger GR, Charney DS (1994) Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients. Arch Gen Psychiatry 51(11):865-874
18. Dunbar G (2009) Positive effects of the nicotinic channel blocker TC-5214 as augmentation treatment in patients with major depressive disorder who are inadequate responders to a first-line SSRI; nAChR2009 satellite meeting of the 39th annual meeting of the Society for Neuroscience; 2009. http://www.faqs.org/sec-filings/091016/TARGACEPT-INC-8-K/dex991.htm
19. Dunbar GC, Kuchibhatla R, Kumar R (2007) Mecamylamine in the treatment of depressed patients who were inadequate responders to citalopram first-line therapy: a double-blind placebo controlled add-on study. J Psychopharmacol 21:A40
20. Dunham JS, Deakin JFW, Miyajima F, Payton A, Toro CT (2009) Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains. J Psychiatr Res 43:1175-1184
21. George TP, Sacco KA, Vessicchio JC, Weinberger AH, Shytle RD (2008) Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: a preliminary study. J Clin Psychopharmacol 28:340-344
22. Gotti C, Zoli M, Clementi F (2006) Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol Sci 27(9):482-491
23. Janowsky D, El-Yousef MK, Davis JM (1974) Acetylcholine and depression. Psychosom Med 36:248-257
24. Kenny PJ, File SE, Neal MJ (2000) Evidence for a complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release. J Neurochem 75:2409-2414
25. Kunugi H, Ida I, Owashi T (2006) Assessment of the dexamethasone/CRH test as a statedependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a multicenter study. Neuropsychopharmacology 31:212-220
26. Kunugi H, Hori H, Adachi N, Numakawa T (2010) Interface between hypothalamic-pituitary-adrenal axis and brain-derived neurotrophic factor in depression. Psychiatry Clin Neurosci 64:447-459
27. Ledford H (2011) Depression drug disappoints: failure of a promising compound casts a shadow on others. Nature 479:278
28. Lippiello PM, Beaver JS, Gatto GJ, James JW, Jordan KG, Traina VM, Xie J, Bencherif M (2008) Tc-5214 (S-(+)-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activity. CNS Neurosci Ther 14(4):266-277
29. Ma Z, Pearson E, Isgor C, Tao R (2006) Evidence of reuptake inhibition responsible for mecamylamine-evoked increases in extracellular serotonin. Brain Res 1073-1074:321-324
30. Mihailescu S, Palomero-Rivero M, Meade-Huerta P, Maza-Flores A, Drucker-Colin R (1998) Effects of nicotine and mecamylamine on rat dorsal raphe neurons. Eur J Pharmacol 360:31-36
31. Mineur YS, Somenzi O, Picciotto MR (2007) Cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male C57BL/6J mice. Neuropharmacology 52(5):1256-1262
32. Nakamura K, Tanaka Y (2001) Antidepressant-like effects of aniracetam in aged rats and its mode of action. Psychopharmacology (Berlin) 158:205-212
33. Newman MB, Manresa JJ, Sanberg PR, Shytle RD (2002) Anxiolytic effects of mecamylamine in two animal models of anxiety. Exp Clin Psychopharmacol 10(1):18-25
34. Newman MB, Nazian SJ, Sanberg PR, Diamond DM, Shytle RD (2001) Corticosterone attenuating and anxiolytic properties of mecamylamine in the rat. Prog Neuropsychopharmacol Biol Psychiatry 25:609-620
35. Philip, N.S., Carpenter, L.L., Tyrka, A.R., Price, L.H., (2012). The nicotinic acetylcholine receptor as a target for antidepressant drug development. ScientificWorldJournal 2012:104105. doi: 10.1100/2012/104105
36. Pick M, Flores-Flores C, Soreq H (2004) From brain to blood: alternative splicing evidence for the cholinergic basis of Mammalian stress responses. Ann N Y Acad Sci 1018:85-98
37. Popik P, Kozela E, Krawczyk M (2003) Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram. Br J Pharmacol 139(6):1196-1202
38. Rabenstein RL, Caldarone BJ, Picciotto MR (2006) The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not β2- or α7-nicotinic acetylcholine receptor subunit knockout mice. Psychopharmacology 189(3):395-401
39. Raber J, Koob GF, Bloom FE (1995) Interleukin-2 (il-2) induces corticotropin-releasing factor (crf) release from the amygdala and involves a nitric oxide-mediated signaling: comparison with the hypothalamic response. J Pharmacol Exp Ther 272(2):815-824
40. Renard CE, Dailly E, David DJP, Hascoet M, Bourin M (2003) Monoamine metabolism changes following the mouse forced swimming test but not the tail suspension test. Fundam Clin Pharmacol 17(4):449-455
41. Réus GZ, Abelaira HM, Stringari RB, Fries GR, Kapczinski F, Quevedo J (2012) Memantine treatment reverses anhedonia, normalizes corticosterone levels and increases BDNF levels in the prefrontal cortex induced by chronic mild stress in rats. Metab Brain Dis 27(2):175-182
42. Rezin GT, Cardoso MR, Gonçalves CL, Scaini G, Fraga DB, Riegel RE (2008) Inhibition of mitochondrial respiratory chain in brain of rats subjected to an experimental model of depression. Neurochem Int 53:395-400
43. Salín-Pascual RJ, Rosas M, Jimenez-Genchi A, Rivera-Meza BL, Delgado-Parra V (1996) Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression. J Clin Psychiatry 57(9):387-389
44. Seth P, Cheeta S, Tucci S, File SE (2002) Nicotinic-serotonergic interactions in brain and behaviour. Pharmacol Biochem Behav 71:795-805
45. Shytle RD, Silver AA, Sanberg PR (2000) Comorbid bipolar disorder in Tourette's syndrome responds to the nicotinic receptor antagonist mecamylamine (Inversine). Biol Psychiatry 48(10):1028-1031
46. Shytle RD, Silver AA, Sheehan KH, Sheehan DV, Sanberg PR (2002) Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine. Depress Anxiety 16(3):89-92
47. Silver AA, Shytle RD, Sanberg PR (2000) Mecamylamine in Tourette's syndrome: a two-year retrospective case study. J Child Adolesc Psychopharmacol 10(2):59-68
48. Silver AA, Shytle RD, Sheehan KH, Sheehan DV, Ramos A, Sanberg PR (2001) Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder. J Am Acad Child Adolesc Psychiatry 40(9):1103-1110
49. Tizabi Y, Getachew B, Rezvani AH, Hauser SR (2009) Overstreet DH antidepressant-like effects of nicotine and reduced nicotinic receptor binding in the fawn-hooded rat, an animal model of co-morbid depression and alcoholism. Prog Neuropsychopharmacol Biol Psychiatry 33(3):398-402
50. Tõnisaar M, Mällo T, Eller M, Häidkind R, Kõiv K, Harro J (2008) Rat behaviour after chronic variable stress and partial lesioning of 5-HT-ergic neurotransmission: effects of citalopram. Prog Neuropsychopharmacol Biol Psychiatry 32:164-177
51. Wiesbeck GA, Kuhl HC, Yaldizli O, Wurst FM (2008) WHO/ISBRA Study Group on Biological State and Trait Markers of Alcohol Use and Dependence. Tobacco smoking and depression - results from the WHO/ISBRA study. Neuropsychobiology 57(1-2):26-31
52. Willner P (1991) Animal models of depression. In: Willner P (ed) Behavioural models in psychopharmacology: theoretical, industrial and clinical perspectives. Cambridge University Press, Cambridge, pp 91-124
53. Willner P, Scheel-Krüger J, Belzung C (2013) The neurobiology of depression and antidepressant action. Neurosci Biobehav Rev 37:2331-2371
54. Yan W, Zhang T, Jia W, Sun X, Liu X (2011) Chronic stress impairs learning and hippocampal cell proliferation in senescence-accelerated prone mice. Neurosci Lett 490:8
55. Yang J, Pei Y, Pan Y, Jia J, Shi C, Yu Y, Deng J, Li B, Gong X, Wang X, Ma X (2013) Enhanced antidepressant-like effects of electroacupuncture combined with citalopram in a rat model of depression. J Evid Based Complementary Altern Med. doi: 10.1155/2013/107380